South Korea Drug Pricing Strategies Needed Now, Says Merck KGaA's South Korean President Juergen Koenig
This article was originally published in The Pink Sheet Daily
Executive Summary
To ramp up pharmaceutical sales, the company may have to overcome some considerable challenges directly linked to the country's increasingly indebted health care system.